Rebecca Fink

Overview

Rebecca Fink, MPH, is a Principal Research Scientist with 13 years of experience designing and implementing multisite epidemiologic research studies, online panel surveys, public health interventions, and evaluations for clients such as CDC, NIH, and HRSA. Her areas of expertise include infectious diseases epidemiology, maternal and child health, multisite study coordination, protocol development, survey design, data management, and data analysis. She is the Project Director for the CDC-funded National SARS-CoV-2 Seroprevalence Studies in Blood Donors project. This project built off work conducted as part of the NIH-funded REDS Epidemiology, Surveillance, and Preparedness of the Novel SARS-CoV-2 Epidemic program, for which Fink served as the Project Manager. She also serves as the Deputy Project Director for a CDC-funded Phase IV trial to examine the relative efficacy of a second-generation influenza vaccine as compared to a standard dose vaccine.

In earlier work, Fink served as Project Director for CDC-funded online panel surveys to monitor vaccination coverage and practices in pregnant women, health care personnel, and a general adult population. Fink has coauthored numerous peer-reviewed publications on SARS-CoV-2 seroprevalence and influenza vaccination coverage.

Education

• MPH, School of Public Health, Boston University, Epidemiology and Biostatistics
• BS (magna cum laude), Boston University, Health Science